Ambu has been granted the 510K clearance for the Ambu® aScope™ by the American health care authorities (Food and Drug Administration-FDA. The Ambu® aScope™ consists of two parts, the single-use videoscope and a monitor. With this clearance, the products, which were launched in the European market around New Year 2009, can now be launched, marketed and sold in the American market. Further information: Lars Marcher, CEO, phone +45 5136 2490, e-mail: lm@ambu.com
The American Health Care Authorities have cleared Ambu's single-use videoscope, Ambu® aScope™
| Source: Ambu A/S